Additional file 2. Circulating levels of (A) PEDV IgG antibody secreting cells (ASCs), (B) PEDV IgG antibodies (Abs), (C) PEDV virus neutralizing (VN) Abs, (D) CD4+ T cells and (E) CD8+ T cells in mock, mock + VA, PEDV and PEDV + VA gilts at post-infection day (PID) 0, 6–8 and 13–17. Asterisks indicate significant differences among treatment groups at the same time point (mean ± SEM). Statistical analysis was performed using the two-way ANOVA with repeated measures and Bonferroni’s correction for multiple comparisons. *P < 0.05 **P < 0.01 ***P < 0.001.
|Date made available||30 Nov 2019|
|Publisher||Figshare - Springer|